comparing cardiovascular and kidney outcomes with tirzepatide vs. glp-1 agonists

comparing cardiovascular and kidney outcomes with tirzepatide vs. glp-1 agonists Association of glucagon-like peptide-1 receptor in type 2 diabetic kidney transplant recipients | Cardiovascular Diabetology comparing cardiovascular and kidney outcomes

Name: comparing cardiovascular and kidney outcomes with tirzepatide vs. glp-1 agonists Association of glucagon-like peptide-1 receptor in type 2 diabetic kidney transplant recipients | Cardiovascular Diabetology comparing cardiovascular and kidney outcomes
Brand: aeroscroll.com
SKU: 3078435258
Price: 27.63 USD
Availability: InStock
Rating: 4.4878 (18 reviews)

SKU: 3078435258

4.5

USD27.63 USD52.63

Pay in 4 interest-free payments of $6.91 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 14 - Aug 19

Description

A pilot study published in Scientific Reports (October 2025) found that people taking GLP-1 receptor agonists had lower peak breath alcohol concentrations and delayed onset of intoxication compared to controls drinking the same amount

This chapter reviews (i) the main scientific information on GPxs and the GSH system and their location in subcellular organelles and changes during aging